The Myeloproliferative Disorder Treatment Market is witnessing steady expansion as advances in hematology research and targeted medicines continue to improve patient care for chronic blood disorders. According to Polaris Market Research, the global Myeloproliferative Disorder Treatment Market was valued at USD 9.53 billion in 2023 and is projected to reach USD 13.13 billion by 2032, growing at...